Evaluation of the association of single nucleotide polymorphisms in the sodium glucose cotransporter 2 gene with glucose homeostasis and type 2 diabetes

被引：0
|
作者：
Muendlein, Axel [1 ]
Ebner, Janine [1 ]
Leiherer, Andreas [1 ,3 ]
Saely, Christoph [1 ,2 ,3 ]
Geiger, Kathrin [1 ]
Brandtner, Eva-Maria [1 ]
Zanolin, Daniela [1 ]
Vonbank, Alexander [1 ,2 ]
Ebner, Karl-Martin [1 ,2 ]
Schuler, Alexandra [1 ,2 ]
Schwerzler, Peter [1 ,2 ]
Mader, Arthur [1 ,2 ]
Fraunberger, Peter [5 ]
Drexel, Heinz [1 ,3 ,4 ]
机构：
[1] VIVIT Inst, Feldkirch, Austria
[2] Acad Teaching Hosp, Feldkirch, Austria
[3] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[4] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[5] Med Cent Lab, Feldkirch, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2017年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P08
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
  • [31] Sodium-glucose cotransporter 2 inhibitors and death and heart failure in type 2 diabetes
    Yanai, Hidekatsu
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
  • [32] Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes
    Dawwas, Ghadeer K.
    Smith, Steven M.
    Park, Haesuk
    DIABETES OBESITY & METABOLISM, 2019, 21 (01): : 28 - 36
  • [33] CANAGLIFLOZIN Sodium/Glucose Cotransporter 2 Inhibitor Treatment of Type 2 Diabetes Treatment of Obesity
    Chao, E. C.
    DRUGS OF THE FUTURE, 2011, 36 (05) : 351 - 357
  • [34] Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes
    Paik, Julie M.
    Tesfaye, Helen
    Curhan, Gary C.
    Zakoul, Heidi
    Wexler, Deborah J.
    Patorno, Elisabetta
    JAMA INTERNAL MEDICINE, 2024, 184 (03) : 265 - 274
  • [35] Canagliflozin, an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus
    Lamos, Elizabeth M.
    Younk, Lisa M.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (06) : 763 - 775
  • [36] Safety of sodium-glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations
    Davidson, Jaime A.
    Sukor, Norlela
    Hew, Fen-Lee
    Mohamed, Mafauzy
    Hussein, Zanariah
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (02) : 167 - 182
  • [37] Sodium-glucose cotransporter-2 inhibitors and fractures in type 2 diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2022, 18 (02): : 198 - 199
  • [38] Efficacy of sodium glucose cotransporter 2 inhibitors as an adjunct treatment for patients with diabetes type 2
    Pujante, Pedro
    Ares, Jessica
    Macia, Carmen
    Rodriguez Escobedo, Racil
    Menendez, Edelmiro
    Delgado, Elias
    MEDICINA CLINICA, 2019, 152 (11): : 438 - 441
  • [39] Sodium glucose cotransporter 2 inhibition with empagliflozin reduces microalbuminuria in patients with type 2 diabetes
    Cherney, D.
    von Eynatten, M.
    Lund, S. S.
    Kaspers, S.
    Crowe, S.
    Woerle, H. J.
    Hach, T.
    DIABETOLOGIA, 2014, 57 : S333 - S333
  • [40] Impact of Sodium Glucose Cotransporter 2 Inhibitors on Weight in Patients With Type 2 Diabetes Mellitus
    Barnett, Anthony H.
    POSTGRADUATE MEDICINE, 2013, 125 (05) : 92 - 100
12345